BEACON Trial: For Investigators

A randomised phase IIb trial of BEvACizumab added to Temozolomide ± IrinOtecan for children with refractory/relapsed Neuroblastoma - BEACON Trial

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. Return both documents to the BEACON-Neuroblastoma Trial Office.

Trial Documents

Links to the current protocol, Patient Information Sheet and Informed Consent Form are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below.

If you cannot find what you are looking for please email the BEACON-Neuroblastoma Trials Office.

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control Log. A link to the Version Control List used in this trial is below.

Amendments

Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

Case Report Form

Guidelines

Other Trial Documents

News and Events

Contact Details

Chief Investigator

Dr Lucas Moreno                                                                                  

Cancer Research UK Consultant in Paediatric Oncology

Cancer Research UK Clinical Trials Unit (CRCTU)
School of Cancer Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Tel: +44 (0) 121 414 3788 

Email: lucas.moreno@vallhebron.cat 

Beacon Trial Office

Trial Coordinator:  Bethany Logan
Trial Monitor:   Shaneed Hajee
Trial Management Team Leader:  Charlotte Firth
Trial Statistician: Rebekah Weston

Cancer Research UK Clinical Trials Unit (CRCTU)
School of Cancer Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Enquiries

Telephone: +44 (0) 121 414 3788 
Fax: +44 (0) 121 414 9520
Email: beacon@trials.bham.ac.uk

Trial Entry

Recruitment to the BEACON-Neuroblastoma trial is now closed.

Serious Adverse Event Reporting

SAE's should be emailed to the BEACON-Neuroblastoma Trial Office, CRCTU, University of Birmingham, UK

reg@trials.bham.ac.uk

Sponsor

University of Birmingham

CRCTU Home Page

http://www.birmingham.ac.uk/crctu